GSKGSK plc
52.41USDMkt Cap: 104.97B $P/E: 16.433d ago
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap104.97B $
Enterprise Value119.72B $
Revenue (TTM)33.20B $
Gross Profit23.65B $
Net Income (TTM)5.72B $
Revenue/Share16.51 USD
Last Price52.41 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees66.8K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)16.43
P/E (Forward)10.20
PEG104.84
EV/EBITDA11.07
EV/Revenue3.61
P/S3.16
P/B4.39
EPS (TTM)3.20
EPS (Forward)5.14
52W Range
51.3986% of range52.57
52W High52.57 USD
52W Low51.39 USD
Profitability
Gross Margin72.40%
Oper. Margin30.94%
EBITDA Margin32.58%
Profit Margin17.50%
ROE34.90%
ROA9.35%
Growth
Revenue Growth5.30%
Earnings Growth-69.50%
Cash Flow & Leverage
Operating CF7.74B $
CapEx (TTM)2.98B $
FCF Margin10.49%
FCF Yield3.32%
Net Debt15.19B $
Net Debt/EBITDA1.40
Balance Sheet
Debt/Equity1.08
Current Ratio0.81
Quick Ratio0.52
Book Value/Sh11.93 USD
Cash/Share1.550 USD
Dividends
Fwd Div Rate1.820 USD
Trail. Div Rate0.6800 USD
Div. Yield3.47%
5Y Avg Yield4.32%
Payout Ratio56.79%
Ex-Div DateAug 14, 2026
Pay DateOct 8, 2026
Splits
Last Split1226:1000
Split DateJul 22, 2022
Analyst Consensus
Rating2.9 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)58.08 USD
Upside (mean)+10.8%
Target Range47.00 USD – 70.00 USD
$47.00+10.8% to mean$70.00
# Analysts8
Ownership
Shares Out.2.00B
Float1.94B
Insiders0.06%
Institutions17.49%
Short Interest
Short Ratio3.2d
Short % Float0.73%
Short % Out.0.72%
Shares Short14.52M
Short (prev mo.)12.76M
Technical
SMA 5051.87 (+1.0%)
SMA 20052.11 (+0.6%)
Beta0.29
S&P 52W Chg19.18%
Avg Vol (30d)2.23M
Avg Vol (10d)3.21M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—